Elite members get real-time data, technical charting, alerts, and no ads - starting at $24.96/mo.
Try Elite for Free
Last Close
11.46
Oct 23 • 3:53 PM ET Dollar change+0.25 Percentage change(2.23%)
Aftermarket Close
11.46
Aftermarket • 7:30 PM ET Dollar change0.00 Percentage change(0.00%)
Category
Equity - Leveraged / Inverse
Sponsor
ProShares
Fund Family
Index
NASDAQ Biotechnology Index
Index Weighting
Active/Passive
Expense
0.95%
Inverse/Leveraged
IPO
Apr 08, 2010
Asset Type
Equities (Stocks)
ETF Type
Bond Type
Average Maturity
Commodity Type
Quant Type
ESG Type
Dividend Type
Structure Type
Growth/Value
Market Cap
Option/Short
Yes / Yes
Tags
Tags
Tags
Tags
Tags
Tags
-
Tags
-
Sector/Theme
Region
SMA20
-1.27%
SMA50
-0.12%
SMA200
-24.79%
Return% 1Y
-49.18%
Return% 3Y
-34.88%
Return% 5Y
-19.44%
Return% 10Y
Return% SI
Flows% 1M
0.00%
Flows% 3M
0.00%
Flows% YTD
30.61%
Flows% 1Y
Flows% 3Y
Flows% 5Y
Trades
Total Holdings
7
AUM
1.90M
NAV/sh
52W High
23.56 -51.36%
52W Low
10.51 9.04%
Volatility
3.32% 3.13%
ATR (14)
0.44
RSI (14)
48.25
Beta
-1.23
Rel Volume
1.64
Avg Volume
8.69K
Volume
14,251
Perf Week
-5.19%
Perf Month
1.73%
Perf Quarter
-16.73%
Perf Half Y
-33.59%
Perf YTD
-39.56%
Perf Year
-51.14%
Perf 3Y
-77.02%
Perf 5Y
-69.86%
Perf 10Y
-96.06%
Prev Close
11.21
Price
11.46
Change %
2.23%
ProShares UltraShort Nasdaq Biotechnology seeks daily investment results that correspond to two times the inverse (-2x) of the daily performance of the Nasdaq Biotechnology Index. The fund invests in financial instruments that ProShare Advisors believes, in combination, should produce daily returns consistent with the fund's investment objective. The index is a modified capitalization weighted index that includes securities of Nasdaq listed companies that are classified as either biotechnology or pharmaceutical. The fund is non-diversified.